(RTTNews) - Viatris (VTRS) announced the launch in Canada of Gen-Clozapine orally disintegrating tablets, providing a new treatment option for treatment-resistant schizophrenia patients. This marks the first availability in Canada of an orally disintegrating tablet of clozapine. Gen-Clozapine orally disintegrating tablets are available by prescription only and through the GenCAN patient support program.
Viatris Canada's Country Manager Jeffrey Long said: "The launch of Gen-Clozapine orally disintegrating tablets demonstrates further evidence of our commitment to providing diversified treatment options to patients and healthcare professionals in Canada."
For More Such Health News, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
